摘要 |
<p>This invention discloses novel carbostyril derivatives represented by the general formula (I) (I) wherein R1 and R2, which may be the same or different, each represents a hydrogen atom, a cycloalkylcarbonyl group, a cycloalkylalkanoyl group, a benzoyl group, an alkanoyl group or a phenylalkylcarbonyl group; R4 represents a hydrogen atom or an alkyl group, R5 and R6, which may be the same or different, each represents a hydrogen atom, an alkyl group, a cycloalkyl group, or a phenylalkyl group, or R5 and R6 may, when taken together with the nitrogen atom to which they are attached, form a S- or 6-membered substituted or unsubstituted heterocyclic ring containing 1 or 2 nitrogen or oxygen atoms as hetero atoms; and the ring A has a partial structure: or wherein R3 represents a hydrogen atom, a cycloalkylcarbonyl group, a cycloalkylalkanoyl group, a benzoyl group, an alkanoyl group or a phenylalkylcarbonyl group, with the proviso that at least one of R1, R2 and R3 when R3 is present, or at least one of R1 and R2, represents a cycloalkylcarbonyl group, a cycloalkylalhanoyl group, a benzoyl group, an alkanoyl group or a phenylalkylcarbonyl group; and pharmaceutically acceptable bstract continued: acid addition salts of the carbostyril derivatives of the formula (I). Process for the preparation of these novel carbostyril compounds are also disclosed. These compounds exhibit excellent .beta.-adrenoreceptor stimulating activity and are useful as therapeutic agents such as bronchodilators, peripheral vasodilators, antihypertensive agents and the like.</p> |